Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Cosmecca Korea Co., Ltd.
WARNING LETTER
•Cosmecca Korea Co., Ltd.•September 22, 2017

Cosmecca Korea Co., Ltd. – FDA Warning Letter, Sep 22, 2017

Record Details

The FDA issued a Warning Letter to Cosmecca Korea Co., Ltd. following an inspection from September 18-22, 2017, identifying significant violations of current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals, rendering their drug products adulterated.

Key violations include: 1. **Failure to test drug products prior to release (21 CFR 211.165(a)):** The firm released OTC drug products without supporting analytical data for conformance to specifications, and a lab personnel admitted not testing every lot. 2. **Incomplete laboratory records and data falsification (21 CFR 211.194(a)):** An investigator documented multiple instances of falsified laboratory records, with a quality control employee admitting to manipulating electronic data for untested products. The firm's response indicated the quality assurance manager instructed this manipulation. 3. **Quality control unit failure to review and approve records (21 CFR 211.192):** Batch records for an OTC sunscreen product contained inaccurate concentration values for active ingredients, leading to the release of an out-of-specification (superpotent) lot. 4. **Inadequate controls over computer systems (21 CFR 211.68(b)):** Laboratory equipment lacked restricted access, with shared usernames/passwords and administrator rights, preventing traceability of data changes. 5. **Failure to establish

Company
Cosmecca Korea Co., Ltd.
Inspection date
September 22, 2017
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · c6771901-bd6e-4bc4-8d90-8cd765ca0194

Violation Codes10
21 CFR 21021 CFR 211FD&C Act 501(a)(2)(B)21 CFR 211.165(a)21 CFR 211.194(a)21 CFR 211.19221 CFR 211.68(b)21 CFR 211.160(b)21 CFR 211.34FD&C Act 801(a)(3)

Full citation text and observation details available on the Dashboard.

Other documents for Cosmecca Korea Co., Ltd.
  • 483 - 2024-09-13September 13, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cosmecca Korea Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.